Bioventus Inc. (BVS)

NASDAQ: BVS · Real-Time Price · USD

13.84

+0.05 (0.36%)

At close: Aug 28, 2026, 4:00 PM EDT

13.84

0.00 (0.00%)

Pre-market: Aug 31, 2026, 8:50 AM EDT

Bioventus Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	581.85	568.09	573.28	512.35	512.12	430.9
Revenue Growth	3.14%	-0.91%	11.89%	0.04%	18.85%	34.17%
Gross Profit	399.45	388.16	388.23	328.19	331.08	302.71
Operating Income	60.61	56.34	36.63	2.03	-34.66	21.05
Net Income	54.46	22.73	-36.13	-156.23	-158.7	-6.6
Earnings Per Share	0.78	0.33	-0.56	-2.49	-2.59	-0.15
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
U.S.	513.71	502.1	506.81	449.86	455.25	387.55
International	68.14	65.99	66.47	62.49	56.87	43.35
Total	581.85	568.09	573.28	512.35	512.12	430.9

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	30.39	51.24	41.58	36.96	30.19	43.93
Total Debt	263.75	311.35	356.06	420.62	436.1	376.22
Net Cash (Debt)	-233.36	-260.11	-314.47	-383.66	-405.92	-332.29
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.35	-3.77	-4.87	-6.12	-6.61	-7.31

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	96.87	74.67	38.8	15.34	-13.54	22.99
Capital Expenditures	-2.59	-2.56	-1.01	-7.36	-11.52	-13.52
Free Cash Flow	94.29	72.11	37.79	7.98	-25.06	9.47
Free Cash Flow Growth	176.51%	90.83%	373.43%	-	-	-82.85%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	68.65%	68.33%	67.72%	64.06%	64.65%	70.25%
Operating Margin	10.42%	9.92%	6.39%	0.40%	-6.77%	4.88%
Pretax Margin	6.64%	4.53%	-9.13%	-23.64%	-36.91%	2.20%
Profit Margin	9.36%	4.00%	-6.30%	-30.49%	-30.99%	-1.53%
FCF Margin	16.20%	12.69%	6.59%	1.56%	-4.89%	2.20%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.70	21.92	-	-	-	-
Forward PE	17.35	9.79	20.00	21.82	17.17	21.50
P/FCF Ratio	12.34	6.91	18.16	41.57	-	90.94
PS Ratio	2.00	0.88	1.20	0.65	0.32	2.00